|
|
Volumn 10, Issue 11, 2011, Pages 2016-
|
|
PI3K inhibitors for cancer treatment: Five years of preclinical and clinical research after BEZ235
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
1 (1 CYANO 1 METHYLETHYL) 3 METHYL 8 (3 QUINOLINYL)IMIDAZO[4,5 C]QUINOLIN 2(1H,3H) ONE;
CANCER CLASSIFICATION;
CANCER GENETICS;
CANCER RESEARCH;
CANCER THERAPY;
CLINICAL RESEARCH;
HUMAN;
NEGATIVE FEEDBACK;
PATIENT CODING;
PERSONALIZED MEDICINE;
PRIORITY JOURNAL;
SHORT SURVEY;
TREATMENT RESPONSE;
ANIMALS;
ANTINEOPLASTIC AGENTS;
HUMANS;
IMIDAZOLES;
PHOSPHATIDYLINOSITOL 3-KINASES;
PROTEIN KINASE INHIBITORS;
PROTEIN KINASES;
QUINOLINES;
|
|
EID: 81055124277
PISSN: 15357163
EISSN: 15388514
Source Type: Journal
DOI: 10.1158/1535-7163.MCT-11-0792 Document Type: Short Survey |
|
Times cited : (17)
|
|
References (0)
|
